Published in J Am Soc Nephrol on February 01, 2004
Benefits and harms of statin therapy for persons with chronic kidney disease: a systematic review and meta-analysis. Ann Intern Med (2012) 3.62
Setting research priorities for patients on or nearing dialysis. Clin J Am Soc Nephrol (2014) 1.97
The exclusion of patients with chronic kidney disease from clinical trials in coronary artery disease. Kidney Int (2006) 1.47
An assessment of the quality of randomised controlled trials conducted in China. Trials (2008) 1.35
Reporting randomised clinical trials of analgesics after traumatic or orthopaedic surgery is inadequate: a systematic review. BMC Clin Pharmacol (2010) 1.27
The landscape of clinical trials in nephrology: a systematic review of Clinicaltrials.gov. Am J Kidney Dis (2013) 1.15
Basic research in nephrology: are we in decline? J Am Soc Nephrol (2012) 1.01
Comparative effectiveness studies to improve clinical outcomes in end stage renal disease: the DEcIDE patient outcomes in end stage renal disease study. BMC Nephrol (2012) 1.00
Fostering innovation, advancing patient safety: the kidney health initiative. Clin J Am Soc Nephrol (2013) 1.00
Impact of treating the metabolic syndrome on chronic kidney disease. Nat Rev Nephrol (2009) 0.96
Frequency and factors influencing publication of abstracts presented at three major nephrology meetings. Int Arch Med (2011) 0.93
Early change in proteinuria as a surrogate end point for kidney disease progression: an individual patient meta-analysis. Am J Kidney Dis (2014) 0.92
Patient recruitment into a multicenter randomized clinical trial for kidney disease: report of the focal segmental glomerulosclerosis clinical trial (FSGS CT). Clin Transl Sci (2012) 0.92
Kidney disease: improving global outcomes. Nat Rev Nephrol (2009) 0.90
The evolution of academic performance in nine subspecialties of internal medicine: an analysis of journal citation reports from 1998 to 2010. PLoS One (2012) 0.90
The natural history of, and risk factors for, progressive chronic kidney disease (CKD): the Renal Impairment in Secondary care (RIISC) study; rationale and protocol. BMC Nephrol (2013) 0.87
Metabolic syndrome and chronic kidney disease: Current status and future directions. World J Nephrol (2014) 0.87
Translational nephrology: what translational research is and a bird's-eye view on translational research in nephrology. Clin Kidney J (2015) 0.87
Establishing a national knowledge translation and generation network in kidney disease: the CAnadian KidNey KNowledge TraNslation and GEneration NeTwork. Can J Kidney Health Dis (2014) 0.85
The CKD Classification System in the Precision Medicine Era. Clin J Am Soc Nephrol (2016) 0.85
Efficacy of galactose and adalimumab in patients with resistant focal segmental glomerulosclerosis: report of the font clinical trial group. BMC Nephrol (2015) 0.84
Assessing the Validity of Surrogate Outcomes for ESRD: A Meta-Analysis. J Am Soc Nephrol (2015) 0.84
Development and evaluation of an instrument for the critical appraisal of randomized controlled trials of natural products. BMC Complement Altern Med (2009) 0.83
Clinical trial in nephrology at hard end point? J Am Soc Nephrol (2004) 0.83
Pragmatic Trials in Maintenance Dialysis: Perspectives from the Kidney Health Initiative. J Am Soc Nephrol (2016) 0.82
The kidney research predicament. J Am Soc Nephrol (2014) 0.81
Are Japanese randomized controlled trials up to the task? A systematic review. PLoS One (2014) 0.81
Deficiencies of effectiveness of intervention studies in veterinary medicine: a cross-sectional survey of ten leading veterinary and medical journals. PeerJ (2016) 0.79
Perceptions and use of the national kidney foundation KDOQI guidelines: a survey of U.S. renal healthcare providers. BMC Nephrol (2013) 0.79
Establishing a clinical trials network in nephrology: experience of the Australasian Kidney Trials Network. Kidney Int (2013) 0.79
Overcoming Barriers in Kidney Health-Forging a Platform for Innovation. J Am Soc Nephrol (2016) 0.79
Impact of a modified data capture period on Liu comorbidity index scores in Medicare enrollees initiating chronic dialysis. BMC Nephrol (2013) 0.79
The next generation of therapeutics for chronic kidney disease. Nat Rev Drug Discov (2016) 0.79
Funding source and the quality of reports of chronic wounds trials: 2004 to 2011. Trials (2014) 0.79
The Evidence-Based Approach to Adult-Onset Idiopathic Nephrotic Syndrome. Front Pediatr (2015) 0.79
Spironolactone to prevent cardiovascular events in early-stage chronic kidney disease (STOP-CKD): study protocol for a randomized controlled pilot trial. Trials (2014) 0.78
Quality research in healthcare: are researchers getting enough statistical support? BMC Health Serv Res (2006) 0.78
The predictive value of arterial stiffness on major adverse cardiovascular events in individuals with mildly impaired renal function. Clin Interv Aging (2016) 0.78
The grand challenge of nephrology. Front Med (Lausanne) (2014) 0.77
Chronic kidney disease prevention--a challenge for Asian countries: report of the Third Asian Forum of Chronic Kidney Disease Initiatives. Clin Exp Nephrol (2012) 0.77
Biomarkers and surrogate endpoints in kidney disease. Pediatr Nephrol (2015) 0.77
Trends in the methodological quality of published randomized controlled trials on antibacterial agents. Br J Clin Pharmacol (2008) 0.76
Novel therapeutic approaches to chronic kidney disease. Br J Clin Pharmacol (2013) 0.75
Drugs and trials: lessons from Plato. Clin Ther (2013) 0.75
Quality of survey reporting in nephrology journals: a methodologic review. Clin J Am Soc Nephrol (2014) 0.75
ESRD Databases, Public Policy, and Quality of Care: Translational Medicine and Nephrology. Clin J Am Soc Nephrol (2016) 0.75
Glomerular Diseases: Registries and Clinical Trials. Clin J Am Soc Nephrol (2016) 0.75
Determination of the optimal case definition for the diagnosis of end-stage renal disease from administrative claims data in Manitoba, Canada. CMAJ Open (2015) 0.75
Pediatric nephrologists' beliefs regarding randomized controlled trials. J Investig Med (2014) 0.75
A retrospective Aliskiren and Losartan study in non-diabetic chronic kidney disease. World J Nephrol (2013) 0.75
Developing Treatments for Chronic Kidney Disease in the 21st Century. Semin Nephrol (2016) 0.75
The future of European Nephrology 'Guidelines'-a declaration of intent by European Renal Best Practice (ERBP). NDT Plus (2009) 0.75
Overview of the publications of rheumatologists after the millennium. Eur J Rheumatol (2015) 0.75
Evaluating association between linguistic characteristics of abstracts and risk of bias: Case of Japanese randomized controlled trials. PLoS One (2017) 0.75
A randomized, controlled trial of early versus late initiation of dialysis. N Engl J Med (2010) 10.33
Cranberries for preventing urinary tract infections. Cochrane Database Syst Rev (2012) 6.38
Accuracy of procalcitonin for sepsis diagnosis in critically ill patients: systematic review and meta-analysis. Lancet Infect Dis (2007) 5.84
Use of corticosteroids in acute lung injury and acute respiratory distress syndrome: a systematic review and meta-analysis. Crit Care Med (2009) 4.90
Meta-analysis: vitamin D compounds in chronic kidney disease. Ann Intern Med (2007) 4.23
Long-term survival of children with end-stage renal disease. N Engl J Med (2004) 4.10
Clinical trials in children. Lancet (2004) 3.97
Effects of antiplatelet therapy on mortality and cardiovascular and bleeding outcomes in persons with chronic kidney disease: a systematic review and meta-analysis. Ann Intern Med (2012) 3.78
Benefits and harms of statin therapy for persons with chronic kidney disease: a systematic review and meta-analysis. Ann Intern Med (2012) 3.62
Acute rejection, T-cell-depleting antibodies, and cancer after transplantation. Transplantation (2014) 3.40
Effects of statins in patients with chronic kidney disease: meta-analysis and meta-regression of randomised controlled trials. BMJ (2008) 3.35
Diagnostic accuracy of urine dipsticks for detection of albuminuria in the general community. Am J Kidney Dis (2011) 3.29
Strategies for increasing recruitment to randomised controlled trials: systematic review. PLoS Med (2010) 3.18
Meta-analysis: erythropoiesis-stimulating agents in patients with chronic kidney disease. Ann Intern Med (2010) 2.97
KDIGO clinical practice guideline for the care of kidney transplant recipients: a summary. Kidney Int (2009) 2.72
Cost-effectiveness of initiating dialysis early: a randomized controlled trial. Am J Kidney Dis (2011) 2.62
HMG CoA reductase inhibitors (statins) for people with chronic kidney disease not requiring dialysis. Cochrane Database Syst Rev (2014) 2.35
Screening and follow-up of living kidney donors: a systematic review of clinical practice guidelines. Transplantation (2011) 2.34
Parents' attitudes to children's participation in randomized controlled trials. J Pediatr (2003) 2.26
Haemoglobin targets: we were wrong, time to move on. Lancet (2007) 2.26
Role of blood pressure targets and specific antihypertensive agents used to prevent diabetic nephropathy and delay its progression. J Am Soc Nephrol (2006) 2.24
Associations between hemodialysis access type and clinical outcomes: a systematic review. J Am Soc Nephrol (2013) 2.22
HMG CoA reductase inhibitors (statins) for dialysis patients. Cochrane Database Syst Rev (2013) 2.21
Fluid and nutrient intake and risk of chronic kidney disease. Nephrology (Carlton) (2011) 2.18
Antibiotics for acute pyelonephritis in children. Cochrane Database Syst Rev (2014) 2.17
Measuring the quality of public open space using Google Earth. Am J Prev Med (2011) 2.11
Antiviral medications to prevent cytomegalovirus disease and early death in recipients of solid-organ transplants: a systematic review of randomised controlled trials. Lancet (2005) 2.09
Enteral vs intravenous rehydration therapy for children with gastroenteritis: a meta-analysis of randomized controlled trials. Arch Pediatr Adolesc Med (2004) 2.03
Pediatricians' attitudes toward randomized controlled trials involving children. J Pediatr (2002) 2.01
Value of routine monitoring of bone mineral density after starting bisphosphonate treatment: secondary analysis of trial data. BMJ (2009) 2.00
Biological variation of high sensitivity cardiac troponin-T in stable dialysis patients: implications for clinical practice. Clin Chem Lab Med (2015) 1.98
Disease-associated bias in T helper type 1 (Th1)/Th2 CD4(+) T cell responses against MAGE-6 in HLA-DRB10401(+) patients with renal cell carcinoma or melanoma. J Exp Med (2002) 1.95
Is low birth weight an antecedent of CKD in later life? A systematic review of observational studies. Am J Kidney Dis (2009) 1.94
Vitamin D compounds for people with chronic kidney disease not requiring dialysis. Cochrane Database Syst Rev (2009) 1.88
The role of surveillance chest X-rays in the follow-up of high-risk melanoma patients. Ann Surg Oncol (2008) 1.87
Prevalence and correlates of self-reported sexual dysfunction in CKD: a meta-analysis of observational studies. Am J Kidney Dis (2010) 1.81
Recurrent pregnancy loss with antiphospholipid antibody: a systematic review of therapeutic trials. Obstet Gynecol (2002) 1.79
Predictors of bleeding complications in percutaneous ultrasound-guided renal biopsy. Kidney Int (2004) 1.79
The motivations and experiences of living kidney donors: a thematic synthesis. Am J Kidney Dis (2012) 1.78
Comparative accuracy of renal duplex sonographic parameters in the diagnosis of renal artery stenosis: paired and unpaired analysis. AJR Am J Roentgenol (2007) 1.77
The impact of neutral-pH peritoneal dialysates with reduced glucose degradation products on clinical outcomes in peritoneal dialysis patients. Kidney Int (2013) 1.75
Retracted Human renal stem/progenitor cells repair tubular epithelial cell injury through TLR2-driven inhibin-A and microvesicle-shuttled decorin. Kidney Int (2013) 1.75
Support interventions for caregivers of people with chronic kidney disease: a systematic review. Nephrol Dial Transplant (2008) 1.74
Abnormal miR-148b expression promotes aberrant glycosylation of IgA1 in IgA nephropathy. J Am Soc Nephrol (2012) 1.73
A novel simpler histological classification for renal survival in IgA nephropathy: a retrospective study. Am J Kidney Dis (2007) 1.73
Evidence-based management of steroid-sensitive nephrotic syndrome. Pediatr Nephrol (2005) 1.72
Long-term antibiotics for preventing recurrent urinary tract infection in children. Cochrane Database Syst Rev (2011) 1.69
Risk factors for nocturnal enuresis in school-age children. J Urol (2009) 1.68
Lower malignancy rates in renal allograft recipients converted to sirolimus-based, calcineurin inhibitor-free immunotherapy: 24-month results from the CONVERT trial. Transplantation (2011) 1.66
Biocompatible dialysis fluids for peritoneal dialysis. Cochrane Database Syst Rev (2014) 1.63
Target of rapamycin inhibitors (sirolimus and everolimus) for primary immunosuppression of kidney transplant recipients: a systematic review and meta-analysis of randomized trials. Transplantation (2006) 1.63
Interleukin 2 receptor antagonists for renal transplant recipients: a meta-analysis of randomized trials. Transplantation (2004) 1.58
Interventions for primary vesicoureteric reflux. Cochrane Database Syst Rev (2011) 1.58
Association of CKD and cancer risk in older people. J Am Soc Nephrol (2009) 1.57
Erythropoiesis-stimulating agents for anaemia in adults with chronic kidney disease: a network meta-analysis. Cochrane Database Syst Rev (2014) 1.55
4. Bedwetting and toileting problems in children. Med J Aust (2005) 1.54
Experiences and perspectives of adults living with systemic lupus erythematosus: thematic synthesis of qualitative studies. Arthritis Care Res (Hoboken) (2013) 1.53
Time on dialysis and cancer risk after kidney transplantation. Transplantation (2013) 1.53
Prevalence of depression in chronic kidney disease: systematic review and meta-analysis of observational studies. Kidney Int (2013) 1.52
HMG CoA reductase inhibitors (statins) for kidney transplant recipients. Cochrane Database Syst Rev (2014) 1.52
HMG CoA reductase inhibitors (statins) for people with chronic kidney disease not requiring dialysis. Cochrane Database Syst Rev (2009) 1.52
miR-1915 and miR-1225-5p regulate the expression of CD133, PAX2 and TLR2 in adult renal progenitor cells. PLoS One (2013) 1.52
Cardiac testing for coronary artery disease in potential kidney transplant recipients. Cochrane Database Syst Rev (2011) 1.52
Clinical practice guidelines on wait-listing for kidney transplantation: consistent and equitable? Transplantation (2012) 1.50
The cost-effectiveness of increasing kidney transplantation and home-based dialysis. Nephrology (Carlton) (2009) 1.48
Health benefits and costs of screening for colorectal cancer in people on dialysis or who have received a kidney transplant. Nephrol Dial Transplant (2012) 1.48
Factors influencing quality of life in children with urinary incontinence. J Urol (2011) 1.47
Interventions for bone disease in children with chronic kidney disease. Cochrane Database Syst Rev (2010) 1.47
Interventions for haemolytic uraemic syndrome and thrombotic thrombocytopenic purpura. Cochrane Database Syst Rev (2009) 1.46
Activated innate immunity and the involvement of CX3CR1-fractalkine in promoting hematuria in patients with IgA nephropathy. Kidney Int (2012) 1.46
Thin glomerular basement membrane disease: clinical significance of a morphological diagnosis--a collaborative study of the Italian Renal Immunopathology Group. Nephrol Dial Transplant (2004) 1.46
Long-term cancer risk of immunosuppressive regimens after kidney transplantation. J Am Soc Nephrol (2010) 1.45
The risk of cancer in recipients of living-donor, standard and expanded criteria deceased donor kidney transplants: a registry analysis. Transplantation (2014) 1.44
Prognostic value of cardiac tests in potential kidney transplant recipients: a systematic review. Transplantation (2015) 1.43
Comparative survival and economic benefits of deceased donor kidney transplantation and dialysis in people with varying ages and co-morbidities. PLoS One (2012) 1.42
Children are not just small adults: the urgent need for high-quality trial evidence in children. PLoS Med (2008) 1.41
The relative benefits and costs of solid phase bead technology to detect preformed donor specific antihuman leukocyte antigen antibodies in determining suitability for kidney transplantation. Transplantation (2015) 1.40
The Initiating Dialysis Early and Late (IDEAL) study: study rationale and design. Perit Dial Int (2004) 1.40
Cost-effectiveness of breast cancer screening in women on dialysis. Am J Kidney Dis (2008) 1.39
Sevelamer: a promising but unproven drug. Nephrol Dial Transplant (2007) 1.39
Parenteral versus oral iron therapy for adults and children with chronic kidney disease. Cochrane Database Syst Rev (2012) 1.39
Catheter-related interventions to prevent peritonitis in peritoneal dialysis: a systematic review of randomized, controlled trials. J Am Soc Nephrol (2004) 1.37
How long should treatments be continued? BMJ (2010) 1.37
Patients' priorities for health research: focus group study of patients with chronic kidney disease. Nephrol Dial Transplant (2008) 1.35
Absolute and relative accuracy of rapid urine tests for urinary tract infection in children: a meta-analysis. Lancet Infect Dis (2010) 1.34
Antifungal agents for preventing fungal infections in non-neutropenic critically ill and surgical patients: systematic review and meta-analysis of randomized clinical trials. J Antimicrob Chemother (2006) 1.34
TLR2 plays a role in the activation of human resident renal stem/progenitor cells. FASEB J (2009) 1.33
Benefits and harms of phosphate binders in CKD: a systematic review of randomized controlled trials. Am J Kidney Dis (2009) 1.31
Patients' experiences and perspectives of living with CKD. Am J Kidney Dis (2009) 1.28
Implementing iron management clinical practice guidelines in patients with chronic kidney disease having dialysis. Med J Aust (2006) 1.28
Management of primary symptomatic lymphocele after kidney transplantation: a systematic review. Transplantation (2011) 1.27
Community preferences for the allocation of solid organs for transplantation: a systematic review. Transplantation (2010) 1.26
Effect of timing of dialysis commencement on clinical outcomes of patients with planned initiation of peritoneal dialysis in the IDEAL trial. Perit Dial Int (2012) 1.25
Interventions for hemolytic uremic syndrome and thrombotic thrombocytopenic purpura: a systematic review of randomized controlled trials. Am J Kidney Dis (2008) 1.22